Theo Audi Yanto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Theo Audi Yanto has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Timotius Ivan Hariyanto
Study Program of Clinical Microbiology, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia
5 shared publications - Akhil Deepak Vatvani
Department of Internal Medicine, NYC Health + Hospitals/Lincoln, New York, NY, USA
4 shared publications - Andree Kurniawan
Department of Internal Medicine, Faculty of Medicine, Pelita Harapan University, Tangerang, Banten, Indonesia
2 shared publications - Nata Pratama Hardjo Lugito
Internal Medicine Department, Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia
2 shared publications Euphemia Seto
Department of Internal Medicine, Siloam Karawaci General Hospital, Pelita Harapan University, Tangerang, Banten, Indonesia
1 shared publication- Gilbert Sterling Octavius
Department of Radiology, Pelita Harapan University, Tangerang, Indonesia
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Korean Pain Society in The Korean Journal of Pain
- Vol. 39 (1) , 144-146
Authors’ reply to the letter to the editor regarding “Low-dose naltrexone for fibromyalgia: a re-analysis suggests lower efficacy than previously reported”
Timotius Ivan Hariyanto, Akhil Deepak Vatvani, Pratik Patel, and Theo Audi Yanto. Korean J Pain 2026;39:144-6. https://doi.org/10.3344/kjp.25362
- 1 January 2026
- Published by Korean Pain Society in The Korean Journal of Pain
- Vol. 39 (1) , 144-146
Open AccessAuthors’ reply to the letter to the editor regarding “Low-dose naltrexone for fibromyalgia: a re-analysis suggests lower efficacy than previously reported”
Timotius Ivan Hariyanto, Akhil Deepak Vatvani, Pratik Patel, and Theo Audi Yanto. Korean J Pain 2026;39:144-6. https://doi.org/10.3344/kjp.25362
- Open Access
- 17 September 2025
- Published by Korean Pain Society in The Korean Journal of Pain
- Vol. 38 (4) , 495-498
Authors’ response to comments on “Efficacy and safety of low-dose naltrexone for the management of fibromyalgia: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis”
Timotius Ivan Hariyanto, Akhil Deepak Vatvani, Pratik Patel, and Theo Audi Yanto. Korean J Pain -0001;0:. https://doi.org/10.3344/kjp.25264
- 17 September 2025
- Published by Korean Pain Society in The Korean Journal of Pain
- Vol. 38 (4) , 495-498
Open AccessAuthors’ response to comments on “Efficacy and safety of low-dose naltrexone for the management of fibromyalgia: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis”
Timotius Ivan Hariyanto, Akhil Deepak Vatvani, Pratik Patel, and Theo Audi Yanto. Korean J Pain -0001;0:. https://doi.org/10.3344/kjp.25264
- Open Access
- 1 January 2025
- Published by XMLink in Journal of Lipid and Atherosclerosis
- Vol. 14 (3) , 326-338
Administration of Sodium-Glucose Cotransporter-2 Inhibitors Following Acute Myocardial Infarction: A Systematic Review, Meta-Analysis, and Meta-Regression of Randomized Trials
Hariyanto TI, et al. J Lipid Atheroscler. 2025 Sep;14(3):326-338. https://doi.org/10.12997/jla.2025.14.3.326
- 1 January 2025
- Published by XMLink in Journal of Lipid and Atherosclerosis
- Vol. 14 (3) , 326-338
Open AccessAdministration of Sodium-Glucose Cotransporter-2 Inhibitors Following Acute Myocardial Infarction: A Systematic Review, Meta-Analysis, and Meta-Regression of Randomized Trials
Hariyanto TI, et al. J Lipid Atheroscler. 2025 Sep;14(3):326-338. https://doi.org/10.12997/jla.2025.14.3.326
- Open Access
- 1 October 2024
- Published by Korean Pain Society in The Korean Journal of Pain
- Vol. 37 (4) , 367-378
Efficacy and safety of low-dose naltrexone for the management of fibromyalgia: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis
Akhil Deepak Vatvani, Pratik Patel, Timotius Ivan Hariyanto, and Theo Audi Yanto. Korean J Pain 2024;37:367-78. https://doi.org/10.3344/kjp.24202
- 1 October 2024
- Published by Korean Pain Society in The Korean Journal of Pain
- Vol. 37 (4) , 367-378
Open AccessEfficacy and safety of low-dose naltrexone for the management of fibromyalgia: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis
Akhil Deepak Vatvani, Pratik Patel, Timotius Ivan Hariyanto, and Theo Audi Yanto. Korean J Pain 2024;37:367-78. https://doi.org/10.3344/kjp.24202
- Open Access
- 18 August 2023
- Published by Universitas Gadjah Mada in Journal of Community Empowerment for Health
- Vol. 6 (2) , 98-105
Validation of Indonesian Version of Telehealth Usability Questionnaire (TUQ)
Introduction: Indonesia is the 4th most populous country globally, with 250 million people spread across 17.508 islands. Despite its strong economic growth, the disparity in poverty increases as the cost of medical care shot up. With inadequate medical care worker-to-patient ratio, telehealth is an alternative to providing healthcare in rural areas with similar or even better satisfaction rates. The lack of a standardized questionnaire in the Indonesian language encouraged the authors to validate Telehealth Usability Questionnaire (TUQ) into the Indonesian language.Methods: A cross-sectional study was done while translation and adaptation of telehealth usability questionnaires were made according to WHO protocol.Results: A total of 102 respondents' data were obtained, which comprised 73.5% female. The overall alpha coefficient was 0.958. The Kaiser–Meyer–Olkin (KMO) sampling test was satisfactory (KMO = 0.926), and the Bartlett test of sphericity was significant (Chi-square = 1835.043; df = 210; p < 0.001). Ease of use and learnability had the highest Cronbach's alpha coefficient (0.907), while reliability had the lowest Cronbach's alpha coefficient (0.794).Conclusion: In conclusion, this questionnaire is one of the first ones, if not the first one, to be validated in the Indonesian language. This set of questions will help assess the usability of the expanding number of telehealth programs available in Indonesia and allow comparisons to determine which features make them more acceptable to users
- 18 August 2023
- Published by Universitas Gadjah Mada in Journal of Community Empowerment for Health
- Vol. 6 (2) , 98-105
Open AccessValidation of Indonesian Version of Telehealth Usability Questionnaire (TUQ)
Introduction: Indonesia is the 4th most populous country globally, with 250 million people spread across 17.508 islands. Despite its strong economic growth, the disparity in poverty increases as the cost of medical care shot up. With inadequate medical care worker-to-patient ratio, telehealth is an alternative to providing healthcare in rural areas with similar or even better satisfaction rates. The lack of a standardized questionnaire in the Indonesian language encouraged the authors to validate Telehealth Usability Questionnaire (TUQ) into the Indonesian language.Methods: A cross-sectional study was done while translation and adaptation of telehealth usability questionnaires were made according to WHO protocol.Results: A total of 102 respondents' data were obtained, which comprised 73.5% female. The overall alpha coefficient was 0.958. The Kaiser–Meyer–Olkin (KMO) sampling test was satisfactory (KMO = 0.926), and the Bartlett test of sphericity was significant (Chi-square = 1835.043; df = 210; p < 0.001). Ease of use and learnability had the highest Cronbach's alpha coefficient (0.907), while reliability had the lowest Cronbach's alpha coefficient (0.794).Conclusion: In conclusion, this questionnaire is one of the first ones, if not the first one, to be validated in the Indonesian language. This set of questions will help assess the usability of the expanding number of telehealth programs available in Indonesia and allow comparisons to determine which features make them more acceptable to users
- 1 April 2022
- Published by Bentham Science Publishers Ltd. in Endocrine, Metabolic & Immune Disorders - Drug Targets
- Vol. 22 (5) , 481-489
Insulin Therapy and Outcome of Coronavirus Disease 2019 (COVID-19): A Systematic Review, Meta-Analysis, and Meta-Regression
Background: Currently, the relationship between insulin therapy and COVID-19 outcome is not yet established. Our study aims to evaluate the possible association between insulin and the composite poor outcome of COVID-19. Methods: We systematically searched the PubMed and Europe PMC database using specific keywords related to our aims until December 12th, 2020. All articles published on COVID-19 and insulin were retrieved. Statistical analysis was done using Review Manager 5.4 and Comprehensive Meta-Analysis version 3 software. Results: Our pooled analysis showed that insulin use was associated with composite poor outcomes of COVID-19 [OR 2.06 (95% CI 1.70 – 2.48), p < 0.00001, I2 = 83%, random-effect modelling], and its subgroup which comprised of risk of COVID-19 [OR 1.70 (95% CI 1.40 – 2.08), p < 0.00001, I2 = 34%, random-effect modelling], severe COVID-19 [OR 2.30 (95% CI 1.60 – 3.30), p < 0.00001, I2 = 88%, random-effect modelling], and mortality [OR 2.14 (95% CI 1.47 – 3.10), p < 0.0001, I2 = 85%, random-effect modelling]. Meta-regression showed that the association was influenced by age (p = 0.008), but not by diabetes p = 0.423) and cardiovascular disease (p = 0.086). Conclusion: Physicians should be more aware and take extra precautions with diabetes patients who use insulin therapy.
- 1 April 2022
- Published by Bentham Science Publishers Ltd. in Endocrine, Metabolic & Immune Disorders - Drug Targets
- Vol. 22 (5) , 481-489
Insulin Therapy and Outcome of Coronavirus Disease 2019 (COVID-19): A Systematic Review, Meta-Analysis, and Meta-Regression
Background: Currently, the relationship between insulin therapy and COVID-19 outcome is not yet established. Our study aims to evaluate the possible association between insulin and the composite poor outcome of COVID-19. Methods: We systematically searched the PubMed and Europe PMC database using specific keywords related to our aims until December 12th, 2020. All articles published on COVID-19 and insulin were retrieved. Statistical analysis was done using Review Manager 5.4 and Comprehensive Meta-Analysis version 3 software. Results: Our pooled analysis showed that insulin use was associated with composite poor outcomes of COVID-19 [OR 2.06 (95% CI 1.70 – 2.48), p < 0.00001, I2 = 83%, random-effect modelling], and its subgroup which comprised of risk of COVID-19 [OR 1.70 (95% CI 1.40 – 2.08), p < 0.00001, I2 = 34%, random-effect modelling], severe COVID-19 [OR 2.30 (95% CI 1.60 – 3.30), p < 0.00001, I2 = 88%, random-effect modelling], and mortality [OR 2.14 (95% CI 1.47 – 3.10), p < 0.0001, I2 = 85%, random-effect modelling]. Meta-regression showed that the association was influenced by age (p = 0.008), but not by diabetes p = 0.423) and cardiovascular disease (p = 0.086). Conclusion: Physicians should be more aware and take extra precautions with diabetes patients who use insulin therapy.
- Open Access
- 1 January 2015
- Published by Medknow in Journal of Global Infectious Diseases
- Vol. 7 (2) , 90-1
Resident medical officer′s knowledge of sepsis: A qualitative study
J Global Infect Dis, Official Publishing of International Infectiologists Network
- 1 January 2015
- Published by Medknow in Journal of Global Infectious Diseases
- Vol. 7 (2) , 90-1
Open AccessResident medical officer′s knowledge of sepsis: A qualitative study
J Global Infect Dis, Official Publishing of International Infectiologists Network